Diabetic Ketoacidosis in a Patient With Glucagonoma
Authors:
- Stephan C. SharpSSStephan C. Sharp
- Michael E. MayMMMichael E. May
- 1 June 1995
- journal article
- case report
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 309 (6) , 326-327
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal.1991
- MALIGNANT SOMATOSTATINOMA PRESENTING WITH DIABETIC KETOACIDOSISClinical Endocrinology, 1987
- The Glucagonoma Syndrome: Clinical Features, Diagnosis, and TreatmentEndocrine Reviews, 1981
- Malignant Glucagonoma Syndrome: Response to ChemotherapyAnnals of Internal Medicine, 1980
- The Glucagonoma SyndromeArchives of internal medicine (1960), 1980
- FAILURE OF SOMATOSTATIN TO CORRECT MANIFEST DIABETIC KETOACIDOSISThe Lancet, 1976
- Prevention of Human Diabetic Ketoacidosis by SomatostatinNew England Journal of Medicine, 1975